UTMD
Income statement / Annual
Last year (2023), Utah Medical Products, Inc.'s total revenue was $50.22 M,
a decrease of 3.93% from the previous year.
In 2023, Utah Medical Products, Inc.'s net income was $16.64 M.
See Utah Medical Products, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$50.22 M
|
$52.28 M
|
$49.05 M
|
$42.18 M
|
$46.90 M
|
$42.00 M
|
$41.41 M
|
$39.30 M
|
$40.16 M
|
$41.28 M
|
| Cost of Revenue |
$20.19 M |
$20.09 M |
$18.14 M |
$16.63 M |
$17.44 M |
$15.69 M |
$15.02 M |
$15.61 M |
$15.97 M |
$16.30 M |
| Gross Profit |
$30.04 M |
$32.20 M |
$30.92 M |
$25.55 M |
$29.47 M |
$26.31 M |
$26.40 M |
$23.69 M |
$24.19 M |
$24.98 M |
| Gross Profit Ratio |
0.6 |
0.62 |
0.63 |
0.61 |
0.63 |
0.63 |
0.64 |
0.6 |
0.6 |
0.61 |
| Research and Development
Expenses |
$560,000.00
|
$493,000.00
|
$526,000.00
|
$486,000.00
|
$483,000.00
|
$454,000.00
|
$447,000.00
|
$475,000.00
|
$522,000.00
|
$460,000.00
|
| General & Administrative
Expenses |
$11.02 M
|
$10.41 M
|
$10.10 M
|
$9.80 M
|
$9.61 M
|
$5.45 M
|
$5.39 M
|
$5.36 M
|
$5.85 M
|
$6.11 M
|
| Selling & Marketing
Expenses |
$1.69 M
|
$1.51 M
|
$1.41 M
|
$1.55 M
|
$1.74 M
|
$1.71 M
|
$1.54 M
|
$1.67 M
|
$2.16 M
|
$2.21 M
|
| Selling, General &
Administrative Expenses |
$12.70 M
|
$11.91 M
|
$11.51 M
|
$11.35 M
|
$11.35 M
|
$7.16 M
|
$6.94 M
|
$7.03 M
|
$8.01 M
|
$8.32 M
|
| Other Expenses |
$0.00 |
$208,000.00 |
$15,000.00 |
$20,000.00 |
-$2,000.00 |
$513,000.00 |
$54,000.00 |
$223,000.00 |
-$46,000.00 |
-$108,000.00 |
| Operating Expenses |
$13.26 M |
$12.41 M |
$12.04 M |
$11.84 M |
$11.83 M |
$7.61 M |
$7.38 M |
$7.50 M |
$8.53 M |
$8.78 M |
| Cost And Expenses |
$33.45 M |
$32.49 M |
$18.14 M |
$28.47 M |
$29.27 M |
$23.30 M |
$22.40 M |
$23.11 M |
$24.51 M |
$25.08 M |
| Interest Income |
$0.00 |
$0.00 |
$166,000.00 |
$112,000.00 |
$254,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$65,000.00 |
$289,000.00 |
| Depreciation &
Amortization |
$6.37 M
|
$7.08 M
|
$7.28 M
|
$7.21 M
|
$6.88 M
|
$2.96 M
|
$2.77 M
|
$2.83 M
|
$3.15 M
|
$3.36 M
|
| EBITDA |
$24.75 M
|
$26.87 M
|
$26.16 M
|
$20.92 M
|
$24.51 M
|
$21.65 M
|
$21.78 M
|
$19.02 M
|
$18.84 M
|
$19.64 M
|
| EBITDA Ratio |
0.49 |
0.38 |
0.63 |
0.33 |
0.38 |
-0.45 |
0.53 |
0.6 |
0.6 |
0.61 |
| Operating Income Ratio
|
0.33
|
0.24
|
0.38
|
0.15
|
0.23
|
0.45
|
0.46
|
0.41
|
0.39
|
0.39
|
| Total Other
Income/Expenses Net |
$3.31 M
|
$869,000.00
|
$181,000.00
|
$132,000.00
|
$252,000.00
|
$762,000.00
|
$71,000.00
|
$235,000.00
|
-$106,000.00
|
-$390,000.00
|
| Income Before Tax |
$20.09 M |
$20.66 M |
$19.06 M |
$13.84 M |
$17.88 M |
$19.46 M |
$19.08 M |
$16.42 M |
$15.55 M |
$15.81 M |
| Income Before Tax Ratio
|
0.4
|
0.4
|
0.39
|
0.33
|
0.38
|
0.46
|
0.46
|
0.42
|
0.39
|
0.38
|
| Income Tax Expense |
$3.45 M |
$4.19 M |
$4.27 M |
$3.04 M |
$3.16 M |
$904,000.00 |
$10.58 M |
$4.29 M |
$3.70 M |
$4.43 M |
| Net Income |
$16.64 M |
$16.47 M |
$14.79 M |
$10.80 M |
$14.73 M |
$18.55 M |
$8.51 M |
$12.13 M |
$11.84 M |
$11.38 M |
| Net Income Ratio |
0.33 |
0.32 |
0.3 |
0.26 |
0.31 |
0.44 |
0.21 |
0.31 |
0.29 |
0.28 |
| EPS |
4.57 |
4.53 |
4.05 |
2.95 |
3.96 |
4.97 |
2.29 |
3.22 |
3.14 |
3.02 |
| EPS Diluted |
4.57 |
4.52 |
4.04 |
2.94 |
3.94 |
4.95 |
2.28 |
3.22 |
3.14 |
3.01 |
| Weighted Average Shares
Out |
$3.64 M
|
$3.64 M
|
$3.65 M
|
$3.66 M
|
$3.72 M
|
$3.73 M
|
$3.72 M
|
$3.75 M
|
$3.77 M
|
$3.77 M
|
| Weighted Average Shares
Out Diluted |
$3.64 M
|
$3.64 M
|
$3.66 M
|
$3.67 M
|
$3.74 M
|
$3.75 M
|
$3.74 M
|
$3.77 M
|
$3.77 M
|
$3.77 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
